medvi quad
Last updated: June 23, 2026
Quick Answer: MEDVi QUAD is a compounded prescription ED medication that combines four active ingredients — Apomorphine, Vardenafil, Sildenafil, and Tadalafil — into a single sublingual tablet. It is available through MEDVi’s telehealth platform starting at $114 per month, with effects reportedly beginning in as little as 10 to 15 minutes and lasting up to 36 hours. It is not FDA-approved as a finished product, but each individual ingredient carries its own FDA approval.
Our Verdict: 4.5/5 — Recommended for Men Seeking a Comprehensive, Telehealth-Delivered ED Solution
Best for: Men over 40 who have not responded fully to single-ingredient ED medications
Best for: Adults wanting fast-onset AND long-duration coverage in one dose
Best for: Men who prefer discreet, online consultations without insurance hassles
Skip if: You have cardiovascular conditions or take nitrate medications — consult your doctor first
Skip if: You are looking for an FDA-approved finished drug product
Key Takeaways
- MEDVi QUAD combines Apomorphine, Vardenafil, Sildenafil, and Tadalafil in one sublingual tablet [1]
- Sublingual delivery means effects can begin in 10 to 15 minutes, with duration up to 36 hours [1]
- The combined 4-in-1 formulation has not undergone independent clinical trials as a finished product [2]
- MEDVi QUAD is a compounded medication and is not FDA-approved as a combined formula [3]
- Pricing starts at $114 per month, including doctor consultation and free rush shipping [4]
- MEDVi holds a 4.5 out of 5 rating on Trustpilot based on user reviews [5]
- In February 2026, the FDA issued a warning letter to MEDVi regarding GLP-1 medications — not MEDVi QUAD specifically [3]
- Medical professionals advise caution for men with cardiovascular conditions due to Apomorphine’s mechanism [7]
- The telehealth model offers convenience, discretion, and no-charge consultations if you do not qualify [4]
- Men evaluating this product should verify the platform’s licensing and consult a licensed clinician before starting [2]
What Is MEDVi QUAD and How Does It Work?
MEDVi QUAD is a compounded prescription medication designed to treat erectile dysfunction by combining four clinically recognized active ingredients into one sublingual tablet. It is prescribed through MEDVi’s telehealth platform after an online doctor consultation.
The four-ingredient approach targets ED from multiple biological angles simultaneously:
- Apomorphine acts on dopamine receptors in the brain to enhance sexual desire and arousal
- Vardenafil inhibits the PDE5 enzyme to increase blood flow to penile tissue, with a relatively fast onset
- Sildenafil (the active compound in Viagra) also inhibits PDE5, reinforcing blood flow effects
- Tadalafil (the active compound in Cialis) provides extended duration, with effects lasting up to 36 hours [1]
The sublingual delivery method — dissolving under the tongue — bypasses first-pass metabolism in the liver, which allows the active ingredients to enter the bloodstream faster than standard oral tablets. Users report effects beginning in as little as 10 to 15 minutes [1].
Why combine all four? Single-ingredient ED medications work for many men, but some individuals respond better to one PDE5 inhibitor than another, and the addition of Apomorphine addresses the psychological or neurological component of arousal that PDE5 inhibitors alone do not target.
Is MEDVi QUAD FDA-Approved and Clinically Tested?
MEDVi QUAD is not FDA-approved as a finished drug product. As a compounded medication, it is not reviewed by the FDA for safety, effectiveness, or quality before it reaches patients [3].
This is a standard feature of the compounding industry, not unique to MEDVi. Compounding pharmacies combine approved ingredients based on individual patient needs. Each of the four active ingredients in MEDVi QUAD carries its own FDA approval for specific indications, but the combined 4-in-1 formula has not been evaluated as a single product by the FDA [3].
On clinical testing: No independent clinical trials have been conducted on the combined MEDVi QUAD formulation as a finished product. This is common in compounding, where individual ingredient evidence is used to support clinical decisions [2].
Important regulatory note: In February 2026, the FDA issued a warning letter to MEDVi concerning misbranding of compounded GLP-1 weight loss medications. That letter did not reference MEDVi QUAD specifically, but it does underscore the importance of scrutinizing any compounded medication platform before enrolling [3].
Bottom line for buyers: If FDA approval of the finished product is a requirement for you, MEDVi QUAD does not meet that bar. If you are comfortable with a compounded formulation using individually approved ingredients, prescribed by a licensed clinician, the risk profile is different.
Who Should — and Should Not — Consider MEDVi QUAD?
MEDVi QUAD is designed for adult men with erectile dysfunction, particularly those who have found single-ingredient PDE5 inhibitors insufficient or inconsistent. It is not appropriate for everyone.
Good candidates include:
- Men who have tried sildenafil or tadalafil alone with partial results
- Men who want both fast onset and extended duration from a single dose
- Men comfortable with telehealth consultations and compounded prescriptions
- Men without insurance who want a cost-transparent, flat-rate pricing model
Men who should avoid MEDVi QUAD or consult a cardiologist first:
- Men taking nitrate medications (the combination can cause dangerous drops in blood pressure)
- Men with a history of cardiovascular disease, recent heart attack, or stroke
- Men with severe liver or kidney impairment
- Men currently taking alpha-blockers for blood pressure or prostate conditions
Medical professionals specifically flag Apomorphine as requiring careful consideration. It is also used in Parkinson’s disease treatment, and its inclusion in an ED formulation adds a layer of pharmacological complexity that warrants a thorough clinical review [7].
Choose MEDVi QUAD if you are a generally healthy adult male who has not achieved satisfactory results with a single ED medication and you want a comprehensive, fast-acting, long-lasting option through a convenient telehealth platform.
MEDVi QUAD Ingredients: A Closer Look
Each ingredient in MEDVi QUAD has a distinct mechanism and clinical history. Here is a breakdown:
| Ingredient | Mechanism | Onset | Duration |
|---|---|---|---|
| Apomorphine | Dopamine receptor agonist (brain) | 10-20 min | Short |
| Vardenafil | PDE5 inhibitor (blood flow) | 15-30 min | 4-6 hours |
| Sildenafil | PDE5 inhibitor (blood flow) | 30-60 min | 4-6 hours |
| Tadalafil | PDE5 inhibitor (blood flow) | 30-60 min | Up to 36 hours |
The sublingual delivery format is designed to accelerate onset across all four ingredients, with users reporting effects in as little as 10 to 15 minutes [1].
Honest assessment: Combining two PDE5 inhibitors (Vardenafil and Sildenafil) in one dose raises a legitimate clinical question about additive side effects. Both target the same enzyme, so the combined dose needs to be calibrated carefully by the prescribing clinician. This is why the telehealth consultation step is not optional — it is the mechanism by which appropriate dosing is determined.
MEDVi QUAD Pricing, Plans, and What Is Included
MEDVi QUAD starts at $114 per month through MEDVi’s telehealth platform [4]. This is competitive for a compounded multi-ingredient ED medication delivered through a full-service telehealth model.
What is included in the subscription:
- Online doctor consultation
- Prescription if you qualify
- Free rush shipping
- 24/7 medical support access
- No charge if you do not qualify medically [4]
Cancellation policy: Patients can cancel at any time, which removes the lock-in risk common with some telehealth subscriptions.
Value comparison: Brand-name Cialis (tadalafil) alone can cost significantly more per month without insurance. For context, our guide on semaglutide without insurance costs shows how telehealth platforms are reshaping the affordability of prescription medications broadly — and the same dynamic applies to ED treatment.
Ready to see if you qualify? Check your eligibility and get started with MEDVi QUAD here.
How Does MEDVi QUAD Compare to Other ED Telehealth Options?
MEDVi QUAD occupies a distinct niche in the compounded ED telehealth market because of its four-ingredient formula. Most competitors offer single-ingredient or dual-ingredient options.
| Feature | MEDVi QUAD | Hims ED | Roman ED |
|---|---|---|---|
| Active Ingredients | 4 (Apomorphine + 3 PDE5i) | 1-2 | 1-2 |
| Delivery Format | Sublingual | Oral tablet | Oral tablet |
| Onset Time | 10-15 min | 30-60 min | 30-60 min |
| Duration | Up to 36 hours | 4-6 hours | Up to 36 hours |
| Starting Price | $114/month | ~$85/month | ~$90/month |
| Telehealth Consult | Included | Included | Included |
| FDA-Approved Formula | No (compounded) | Yes (brand/generic) | Yes (brand/generic) |
The key trade-off: Hims and Roman offer FDA-approved finished drug products, which provides a different regulatory assurance. MEDVi QUAD offers a broader pharmacological approach that may suit men who have not responded to standard single-agent therapy.
For a broader comparison of telehealth ED options, see our review of the best ED medication subscription services and our breakdown of Hims erectile dysfunction reviews in 2026.
If you want the most comprehensive single-dose ED coverage available through telehealth in 2026, MEDVi QUAD is worth evaluating.
Real User Experiences and Trustpilot Ratings
MEDVi QUAD holds a 4.5 out of 5 rating on Trustpilot, indicating a high level of user satisfaction among verified reviewers [5].
Common themes in positive reviews include:
- Faster onset than previous single-ingredient medications
- Reduced anxiety about timing doses before sexual activity
- Satisfaction with the telehealth consultation process
- Appreciation for discreet shipping and packaging
Common concerns noted in reviews:
- Mild side effects including headaches and facial flushing [6]
- Some users noted a learning curve with sublingual administration
- A minority reported the medication was not prescribed after consultation (which is actually the system working as intended — not everyone qualifies)
Side effects to be aware of: As with any PDE5 inhibitor combination, potential side effects include headache, flushing, nasal congestion, and dizziness. Apomorphine can additionally cause nausea in some individuals. These are generally mild and transient, but any persistent or severe symptoms warrant immediate medical attention [6].
MEDVi QUAD and the Broader GLP-1 and Telehealth Landscape
MEDVi is not exclusively an ED platform. The company also offers GLP-1 weight loss medications, including compounded semaglutide, through the same telehealth model. This is relevant context for readers who found MEDVi through weight loss research.
For readers interested in GLP-1 medications for weight loss, MEDVi Semaglutide is positioned as one of the most affordable options in the compounded GLP-1 market. Our detailed guide on GLP-1 medications for weight loss and diabetes covers the full landscape of semaglutide and tirzepatide options available through telehealth in 2026.
The February 2026 FDA warning letter to MEDVi concerned GLP-1 product misbranding — not MEDVi QUAD — but it is a reminder that the compounded medication telehealth space operates under active regulatory scrutiny [3]. Men and women evaluating any platform in this category benefit from verifying provider licensing and reading the fine print before enrolling.
For those comparing GLP-1 platforms specifically, our roundup of the best GLP-1 weight loss programs in 2026 and the most affordable GLP-1 options without insurance offer structured comparisons.
MEDVi Semaglutide — one of the most affordable compounded GLP-1 options available in 2026. Click here to check current pricing and availability.
Pros and Cons of MEDVi QUAD
Pros:
- Four-ingredient formula addresses both neurological arousal and vascular blood flow
- Sublingual delivery for faster onset than standard oral tablets
- Competitive pricing at $114/month including consultation and shipping
- No charge if you do not medically qualify
- 4.5/5 Trustpilot rating from real users
- Convenient, discreet telehealth model with 24/7 support
Cons:
- Not FDA-approved as a finished combined product
- The combined 4-in-1 formula lacks independent clinical trial data
- Combining two PDE5 inhibitors increases potential for side effects
- Apomorphine requires careful screening for cardiovascular and neurological conditions
- Not appropriate for men on nitrates or certain blood pressure medications
Conclusion: Is MEDVi QUAD Worth Trying in 2026?
MEDVi QUAD is a genuinely differentiated product in the compounded ED telehealth market. Its four-ingredient sublingual formula offers faster onset and longer duration than most single-agent alternatives, and the $114/month price point is competitive for what is included.
The honest caveats are real: this is not an FDA-approved finished product, the combined formula lacks independent clinical trial data, and the inclusion of Apomorphine adds pharmacological complexity that requires careful medical screening. These are not reasons to dismiss MEDVi QUAD, but they are reasons to take the consultation process seriously and disclose your full medication list and health history.
Actionable next steps:
- Review your current medications for nitrate or alpha-blocker use before applying
- Complete the MEDVi telehealth consultation honestly — the screening exists to protect you
- Start with the standard dose and give it at least two to three uses before evaluating effectiveness
- Report any persistent headache, dizziness, or nausea to your prescribing clinician
- Revisit your prescription every three to six months to confirm it remains appropriate
Don’t wait — start your MEDVi QUAD consultation today and find out if you qualify. No charge if you don’t.
For men also exploring weight loss support, MEDVi Semaglutide offers the same telehealth convenience at some of the most competitive compounded GLP-1 pricing available in 2026.
Frequently Asked Questions
Does MEDVi QUAD work immediately?
MEDVi QUAD’s sublingual delivery is designed for rapid absorption, with effects reported in as little as 10 to 15 minutes in some users [1]. Individual response times vary based on metabolism, food intake, and overall health.
Is MEDVi QUAD FDA-approved?
No. MEDVi QUAD is a compounded medication and is not FDA-approved as a finished drug product. Each of the four individual active ingredients has its own FDA approval for specific indications, but the combined formulation has not been evaluated by the FDA as a single product [3].
Can I take MEDVi QUAD with other medications?
Not necessarily. MEDVi QUAD is contraindicated with nitrate medications and may interact with alpha-blockers and certain antihypertensives. Always disclose your full medication list during the telehealth consultation. Men with cardiovascular conditions require careful clinical screening before use [7].
How much does MEDVi QUAD cost per month?
MEDVi QUAD starts at $114 per month, which includes the online doctor consultation, prescription (if you qualify), free rush shipping, and 24/7 medical support access [4].
What are the most common side effects of MEDVi QUAD?
The most commonly reported side effects include headache and facial flushing, which are typical of PDE5 inhibitors [6]. Apomorphine can additionally cause nausea in some individuals. Serious side effects are rare but require immediate medical attention if they occur.
How does MEDVi QUAD differ from taking Viagra or Cialis alone?
Viagra (sildenafil) and Cialis (tadalafil) are single-ingredient PDE5 inhibitors. MEDVi QUAD combines both of those compounds plus Vardenafil (another PDE5 inhibitor) and Apomorphine (a dopamine agonist that targets arousal at the neurological level), delivering a broader-spectrum approach in one sublingual dose [1].
What happens if I don’t qualify for MEDVi QUAD?
If the MEDVi clinician determines you do not medically qualify for MEDVi QUAD, you are not charged for the consultation [4]. This no-charge policy removes the financial risk of the evaluation process.
Is MEDVi QUAD the same as MEDVi’s GLP-1 weight loss program?
No. MEDVi QUAD is an ED medication. MEDVi also offers a separate GLP-1 weight loss program featuring compounded semaglutide. Both are delivered through the same telehealth platform but are distinct products for different indications.
Has MEDVi had any regulatory issues?
In February 2026, the FDA issued a warning letter to MEDVi concerning misbranding of compounded GLP-1 weight loss medications. That letter did not reference MEDVi QUAD [3]. However, it highlights the importance of verifying any compounded medication platform’s compliance status before enrolling.
Where is MEDVi located and how can I contact them?
MEDVi’s mailing address is 131 Continental Dr., Ste 305, Newark, DE 19713. They can be reached by email at hello@medvi.org or by phone at +1 (585) 312-4226 [3].
References
[1] Medvi Quad – https://www.ricciofamilypharmacy.com/product/medvi-quad/
[2] Medvi Quad Claims Evaluated Real Online Doctor Approval Ed Medication For Men S Sexual Performance – https://www.globenewswire.com/news-release/2026/04/04/3268204/0/en/medvi-quad-claims-evaluated-real-online-doctor-approval-ed-medication-for-men-s-sexual-performance.html
[3] Medvi Quad Reviewed Compounded Prescription Facts Fda Warning Explained And – https://www.newswire.com/news/medvi-quad-reviewed-compounded-prescription-facts-fda-warning-explained-and
[4] quad.medvi – https://quad.medvi.org/
[5] quad-ed – https://quad-ed.com/
[6] medviquadreviews.us – https://medviquadreviews.us.com/
[7] New York Times Lauded Medvi Is Marketing Quad A Four Drug Ed Cocktail With A Parkinsons Drug Component – https://www.drugdiscoverytrends.com/new-york-times-lauded-medvi-is-marketing-quad-a-four-drug-ed-cocktail-with-a-parkinsons-drug-component/
Tags: MEDVi QUAD, compounded ED medication, telehealth ED treatment, sildenafil tadalafil combination, apomorphine ED, erectile dysfunction 2026, MEDVi review, GLP-1 weight loss, compounded semaglutide, PDE5 inhibitor, online ED prescription, men’s sexual health
